Lifecore Biomedical, Inc. \de\ SEC filings LFCR
Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| PREM14A | Filing | Oct 30, 2026 | Oct 30, 2026 |
| DEFA14A | Additional proxy material | Sep 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 24, 2026 |
| DEF 14A | Proxy statement | Sep 18, 2025 | Sep 18, 2025 |
| DEF 14A | Proxy statement | Feb 27, 2025 | Feb 27, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 21, 2025 | Jan 21, 2025 |
| DEFA14A | Additional proxy material | Jan 17, 2025 | — |
| DEF 14A | Proxy statement | Sep 23, 2024 | Nov 7, 2024 |
| DEFA14A | Additional proxy material | Aug 9, 2024 | — |
| DEF 14A | Proxy statement | Jul 19, 2024 | May 28, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 8, 2024 | May 28, 2023 |
| DEF 14A | Proxy statement | Sep 19, 2022 | Sep 19, 2022 |
| DEF 14A | Proxy statement | Aug 27, 2021 | Oct 20, 2021 |
| DEF 14A | Proxy statement | Aug 31, 2020 | Oct 14, 2020 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2020 | Oct 14, 2020 |
| DEF 14A | Proxy statement | Aug 21, 2019 | Oct 16, 2019 |
| DEF 14A | Proxy statement | Aug 23, 2018 | Oct 12, 2018 |
| DEF 14A | Proxy statement | Aug 24, 2017 | May 28, 2017 |
| DEF 14A | Proxy statement | Aug 26, 2016 | Oct 20, 2016 |
| DEF 14A | Proxy statement | Aug 24, 2015 | Oct 15, 2015 |
| DEF 14A | Proxy statement | Sep 5, 2014 | Oct 9, 2014 |
| DEF 14A | Proxy statement | Aug 21, 2013 | Oct 10, 2013 |
| DEF 14A | Proxy statement | Aug 30, 2012 | Oct 11, 2012 |
| PRE 14A | Preliminary proxy statement | Aug 20, 2012 | Oct 11, 2012 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFCR (Nasdaq)
- Fiscal year ends
- May 25
- Incorporated in
- DE
- Headquarters
- Chaska, MN
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\ (until Nov 7, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.